SPHK2 and alcoholic fatty liver disease: SphK2 can be metabolically protective, as Sphk2−/− predisposes to nonalcoholic and alcoholic fatty liver diseases, whereas adenoviral overexpression of SphK2 primarily in the liver improves insulin resistance (18, –20).